BlueWillow Biologics
Hugo Braun is a partner and co-founder of North Coast Technology Investors, a Michigan-based venture capital firm with over $100 million under management that focuses on early stage investments in IT, advanced materials and life sciences. Prior to North Coast, Hugo worked in San Francisco co-managing BankAmerica’s venture capital portfolio. Hugo holds an M.S. in Management from the Sloan School at MIT and a B.A. in Economics from Yale University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
BlueWillow Biologics
BlueWillow Biologics® is a clinical-stage, privately-held biopharmaceutical company focused on developing and commercializing topical antiseptic and anti-infective products and intranasal vaccines using its patented nanotechnology platform. The platform employs novel oil-in-water nano-droplets for products administered to the skin and nose. The company was founded as a spin-off from the University of Michigan, and was initially focused on developing nano-scale dermatology applications. Based on promising research generated under several Gates Foundation, NIH and DOD contracts, BlueWillow’s technology has been advanced significantly in recent years yielding several therapies in development.